Toggle Offcanvas
...
 
Dapagliflozin Tenders

Dapagliflozin Tenders

View Dapagliflozin tenders, RFPs and contracts. Bid on readily available Dapagliflozin tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Dapagliflozin tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Dapagliflozin.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Dapagliflozin market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Dapagliflozin tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

72 Live Notices for Dapagliflozin Tenders

Showing 1 to 20

Judicial Acquisition Of Medicines: Dapagliflozin, Trimetazidine Dihydrochloride.
country Brazil
posting date05 Feb 2025
deadline20 Feb 2025
Judicial Acquisition Of Medicines: Trimetazidine Dihydrochloride, Dapagliflozin.
country Brazil
posting date05 Feb 2025
deadline20 Feb 2025
Conduct, Supervision And Management Of A Non-Commercial Clinical Trial
country Poland
posting date05 Feb 2025
deadline20 Feb 2025
Subject: Electronic Auction - Supply Of Medicines Listed In The Official Anvisa/Cmed Medicine Price List Relating To Legal Demands Table 6.
country Brazil
posting date04 Feb 2025
deadline18 Feb 2025
Subject: Electronic Auction - Judicial Medicines Broad
country Brazil
posting date04 Feb 2025
deadline19 Feb 2025
* Price Record * Dapagliflozin 10Mg, Empagliflozin 25 Mg, Insulin Degludeca 100 Ui/Ml + Liraglutide 3.6 Mg/Ml, Mycophenolate Mofetil 500Mg, Alpinia Zerumbet 0.08Ml/Ml Dermatological Spray Solution 60Ml, Finerenone 10 Mg, Calcium L-Methylfolate Ofolato G Bottle With 15Ml Of Oral Solution
country Brazil
posting date31 Jan 2025
deadline11 Feb 2025
Delivery Of Program And Other Medications
country Poland
posting date31 Jan 2025
deadline10 Feb 2025
Subject: Electronic Auction - Acquisition Of Medicines To Meet The Specialized Component Of Pharmaceutical Assistance (Ceaf), A Strategy For Access To Medicines Within The Scope Of The Sus, Characterized By The Search For Guaranteeing The Integrality Of Drug Treatment, At An Outpatient Level, Whose Lines Of Care Are Defined In Published Clinical Protocols And Therapeutic Guidelines (Pcdt), Under The Terms Below, According To The Conditions And Requirements Established In This Instrument.
country Brazil
posting date30 Jan 2025
deadline13 Feb 2025
Subject: Electronic Auction - Acquisition Of Medicines To Meet Administrative And Judicial Demands With And Without Brand.
country Brazil
posting date28 Jan 2025
deadline13 Feb 2025
Supply of Dapagliflozin Tablets to the Department of Health
country Hong Kong
posting date24 Jan 2025
deadline26 Feb 2025
Object: Electronic Auction - Acquisition Of Branded Legal Medicines, Duly Specified In Annex I Of The Notice, Through The Price Registration System.
country Brazil
posting date24 Jan 2025
deadline11 Feb 2025
Pharmaceutical Discount Agreements From February 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date12 Dec 2024
deadline02 Dec 2026
Medicines Containing The Active Ingredient Dapagliflozin (Atc: A10Bk01)
country Germany
posting date27 Aug 2024
deadline31 Jul 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Dapagliflozin + Metformin, Atc A10Bd15 (Obo) For The Period 01.10.2024 - 30.09.2026
country Germany
posting date19 Aug 2024
deadline05 Aug 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Dapagliflozin, Atc A10Bk01 (Obo) For The Period 01.10.2024 - 30.09.2026
country Germany
posting date19 Aug 2024
deadline05 Aug 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Dapagliflozin, Atc A10Bk01 (Obo) For The Period 01.10.2024 - 30.09.2026
country Germany
posting date17 Aug 2024
deadline05 Aug 2026
Open House Original Discount Agreements 2023-20 - Metformin/Dapagliflozin (Drug Combination)
country Germany
posting date17 Jun 2023
deadline31 Jul 2025
Open House Original Discount Agreements 2023-20 - Metformin/Dapagliflozin (Drug Combination)
country Germany
posting date17 Jun 2023
deadline31 Jul 2025
Open House Original Discount Agreements 2023-20 - Metformin/Dapagliflozin (Drug Combination)
country Germany
posting date15 Jun 2023
deadline31 Jul 2025
Conclusion Of Non-Exclusive Discount Agreements According To § 130A Abs. 8 Sgb V For The Active Ingredient Dapagliflozin
country Germany
posting date10 May 2023
deadline09 May 2025

Share Share this page